Market Pulse
KIS quote snapshot · Sep 21, 2026 10:00 KST · KIS quote snapshots + ECOS · 30 min refresh
KOSPI
6,975.35
+81.12 (+1.18%)
KOSDAQ
834.08
+6.96 (+0.84%)
KOSPI 200
1,106.28
+16.05 (+1.47%)
USD/KRW
1,383.30
128940KOSPI·Jul 29, 2026
Focus on Beijing Hanmi��s recovery and pipeline progress
Mirae Asset Securities published a company analysis report on Hanmi Pharm. Co., Ltd. (128940) titled "Focus on Beijing Hanmi��s recovery and pipeline progress".
Summary
Covers Hanmi Pharm. Co., Ltd. (128940).
Covered stock
More on 128940
Roche��s answer to Eli Lilly and Novo NordiskMirae Asset Securities · Aug 26, 2026Eli Lilly deal adds to pipeline valueMirae Asset Securities · Jun 04, 2026Sailing With LillyKB Securities · Jun 02, 2026Initiating Coverage: Core Business Recovery; Obesity, R&D NextKB Securities · May 27, 2026First Korean pharma to translate the obesity theme into earningsMirae Asset Securities · Feb 06, 20262Q25 review: Revenue misses, OP beatsMirae Asset Securities · Jul 29, 2025Focus on potential recovery in quarterly earnings and June ADA eventMirae Asset Securities · Feb 05, 2025